Bronchiolitis. Other acute lower respiratory infections
Conditions
Interventions
Intervention 1: Infants who have inclusion criteria and their respiratory rate is between 30 - 60 per minute devide in 3 groups. First group receive 5 ml normal saline 0/9 % and 0/15 mg/kg nebulized s
Treatment - Drugs
Third group receive 5 ml hypertonic saline 5% and 0/15 mg/kg nebulized salbutamol.
Infants who have inclusion criteria and their respiratory rate is between 30 - 60 per minute devide in 3 groups. First group receive 5 ml normal saline 0/9 % and 0/15 mg/kg nebulized salbutamol
Second group receive 5 ml hypertonic saline 3 % and 0/15 mg/kg nebulized salbutamol.
Sponsors
Vice.chancellor for research of Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 2 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age less than 2 year old; history of recent upper respiratory viral infection which caused wheez and crakle in ascultation; CBSS 4-8 in admit. Exclusion criteria: age less than 1 month or more than 2 years old; history of recurrent attack of wheez; sever neurologic disorder; consolidation in Chest x ray; immune deficiency; congenital heart disease; history of prematurity(gestational age less than 34 weeks); birth weight less than 2500 gr; sturation of oxygen less than 85% in room; CBSS less than 4 or more than 8; unstable hemodynamic(heart rate more than 200 per minute,blood pressure 2 standard deviation more or less than normal range for age and sex ,respiratory rate more than 70 per minute).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| O2 saturation. Timepoint: Pretreatment and each 20 minute up to 3 times after the begining of the treatment. Method of measurement: With pulse oximetery.;Respiratory rate. Timepoint: Pretreatment and each 20 minute up to 3 times after the begining of treatment. Method of measurement: Counting of respiratory rate in 1 minute.;Heart rate. Timepoint: Pretreatment and each 20 minute up to 3 times after the begining of teratment. Method of measurement: Counting of the heart rate in 1 minute.;Intercostal retraction. Timepoint: Pretreatment and each 20 minute up to 3 times after the begining of the treatment. Method of measurement: Physical exam and score of CBSS (0,1,2,3).;Dyspnea. Timepoint: Pretreatment and each 20 minute up to 3 times after the begining of the treatment. Method of measurement: Physical examine and score of CBSS(0,1,2,3).;Wheeze. Timepoint: Pretreatment and each 20 minute up to 3 times after the begining of the treatment. Method of measurement: Physical exam and score of the CBSS(0,1,2,3). | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of admission. Timepoint: From admossion up to discharge from hospital. Method of measurement: Counting of the dyes of admission. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Baktash
Zahedan University of Medical Sciences
Outcome results
None listed